神经妥乐平注射剂治疗慢性疼痛性疾病探讨  

Probe into the Treatment of Chronic Painful Diseases with Neurotolpine Injection

作　　者：于慧[1] 孙晶[1] YU Hui;SUN Jing(Pain Department,Affiliated Hospital of Binzhou Medical College,Binzhou Shandong 256600,China)

机构地区：[1]滨州医学院附属医院疼痛科,山东滨州256600

出　　处：《医学食疗与健康》2020年第10期7-8,共2页Medical Diet and Health

摘　　要：目的:分析神经妥乐注射剂治疗慢性疼痛性疾病临床机制。方法:选取2018年2月至2019年3月在我院接受治疗的慢性疼痛性疾病患者120例纳入研究,按照随机数表将所有患者均分成2组,参考组(60例)和一般组(60例)。一般组实施常规治疗,参考组实施神经妥乐注射剂治疗,观察两组患者临床效果以及不良反应发生率。结果:经护理后,较一般组,参考组的临床效果更佳,不良反应显著更小,组间数据对比具有明显的差异,具备统计学意义(P<0.05)。结论:因此可看出,神经妥乐注射剂治疗慢性疼痛性疾病临床效果显著,总体副作用少,可在临床实践应用推广。Objective:To analyze the clinical mechanism of neurotolu injection in the treatment of chronic painful diseases.Methods:120 patients with chronic pain diseases who were treated in our hospital from February 2018 to March 2019 were selected for study.All patients were divided into 2 groups according to the random number table,the reference group(60 cases)and the general group 60 cases).The general group was given conventional treatment,and the reference group was given neurotol injection to observe the clinical effects of the two groups of patients.Results:After nursing,the clinical effect of the reference group was better than that of the general group,and there was a significant difference in data comparison between the groups,with statistical significance(P<0.05).Conclusion:Therefore,it can be seen that the neurotolu injection has a significant clinical effect in treating chronic painful diseases,with fewer overall side effects,and can be applied in clinical practice.

关 键 词：神经妥乐注射剂 慢性疼痛性疾病 临床效果 

分 类 号：R453[医药卫生—治疗学]